| Walmart Pharmacy 10-2051 | |
| 3396 Stockton Hill Rd, Kingman, Arizona 86409 | |
| (928) 692-0444 |
| Name | Walmart Pharmacy 10-2051 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 3396 Stockton Hill Rd, Kingman, Arizona 86409 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (928) 692-0444 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Almost 10% of the world population suffers dyslexia. Establishing an early diagnosis would allow the development of training programs to palliate this disorder.
Just a few genes make enterohaemorrhagic E. coli (EHEC) extremely dangerous to humans. If it were not for these genes, EHEC would hardly differ from harmless enteric bacteria. Bioinformatics scientists from the Saarbr-cken Cluster of Excellence want to exploit this similarity to find starting points for effective drugs against the EHEC pathogen.
The Multiple Myeloma Research Foundation (MMRF) today announced a unique oncology research partnership. This multi-year agreement involves several partners including the Translational Genomics Research Institute (TGen), Spectrum Health, and the Van Andel Research Institute.
Cell Therapeutics, Inc. (CTI) has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for use of Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need.
› Verified 8 days ago
| NPI Number | 1881611093 |
| Organization Name | WALMART INC. |
| Doing Business As | WALMART PHARMACY 10-2051 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3396 N Stockton Hill Rd, Kingman, AZ 86409 |
| Phone Number | 928-692-0444 |
News Archive
Almost 10% of the world population suffers dyslexia. Establishing an early diagnosis would allow the development of training programs to palliate this disorder.
Just a few genes make enterohaemorrhagic E. coli (EHEC) extremely dangerous to humans. If it were not for these genes, EHEC would hardly differ from harmless enteric bacteria. Bioinformatics scientists from the Saarbr-cken Cluster of Excellence want to exploit this similarity to find starting points for effective drugs against the EHEC pathogen.
The Multiple Myeloma Research Foundation (MMRF) today announced a unique oncology research partnership. This multi-year agreement involves several partners including the Translational Genomics Research Institute (TGen), Spectrum Health, and the Van Andel Research Institute.
Cell Therapeutics, Inc. (CTI) has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for use of Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need.
› Verified 8 days ago
News Archive
Almost 10% of the world population suffers dyslexia. Establishing an early diagnosis would allow the development of training programs to palliate this disorder.
Just a few genes make enterohaemorrhagic E. coli (EHEC) extremely dangerous to humans. If it were not for these genes, EHEC would hardly differ from harmless enteric bacteria. Bioinformatics scientists from the Saarbr-cken Cluster of Excellence want to exploit this similarity to find starting points for effective drugs against the EHEC pathogen.
The Multiple Myeloma Research Foundation (MMRF) today announced a unique oncology research partnership. This multi-year agreement involves several partners including the Translational Genomics Research Institute (TGen), Spectrum Health, and the Van Andel Research Institute.
Cell Therapeutics, Inc. (CTI) has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for use of Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need.
› Verified 8 days ago
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2153 E Gordon Drive, Kingman, Arizona 86409 Phone: (928) 692-9401 | |
Cvs Pharmacy #08977 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3501 Stockton Hill Rd, Kingman, Arizona 86409 Phone: (928) 757-1999 | |
Uptown Pharmacy Of Kingman Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2820 E Andy Devine Ave, Kingman, Arizona 86401 Phone: (928) 753-2738 | |
Walmart Pharmacy 10-2051 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3396 Stockton Hill Rd, Kingman, Arizona 86409 Phone: (928) 692-0444 | |
Safeway Pharmacy #1887 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3970 Stockton Hill Rd, Kingman, Arizona 86409 Phone: (928) 681-4903 |